Concepedia

Publication | Closed Access

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.

DOI

681

Citations

15

References

1997

Year

W ten Bokkel Huinink, Martin Gore, J Carmichael, Anderley Gordon, John H. Malfetano, I Hudson, Colin Broom, C Scarabelli, N. Davidson, M Spanczynski,
Journal of Clinical Oncology

Abstract

Topotecan has efficacy at least equivalent to paclitaxel manifested by the higher response rate and significantly longer time to progression.

References

YearCitations

Page 1